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Objective To identify pregnancy-related risk factors for different
manifestations of congenital anorectal malformations (ARMs).
Design A population-based case–control study.
Setting Seventeen EUROCAT (European Surveillance of Congenital
Anomalies) registries, 1980–2008.
Population The study population consisted of 1417 cases with ARM,
including 648 cases of isolated ARM, 601 cases of ARM with additional
congenital anomalies, and 168 cases of ARM-VACTERL (vertebral, anal,
cardiac, tracheo-esophageal, renal, and limb defects), along with 13 371
controls with recognised syndromes or chromosomal abnormalities.
Methods Multiple logistic regression analyses were used to calculate
adjusted odds ratios (ORs) for potential risk factors for ARM, such as
fertility treatment, multiple pregnancy, primiparity, maternal illnesses
during pregnancy, and pregnancy-related complications.
Main outcome measures Adjusted ORs for pregnancy-related risk
factors for ARM.
Results The ARM cases were more likely to be firstborn than
the controls (OR 1.6, 95% CI 1.4–1.8). Fertility treatment and being one
of twins or triplets seemed to increase the risk of ARM in cases with
additional congenital anomalies or VACTERL (ORs ranging from 1.6 to
2.5). Maternal fever during pregnancy and pre-eclampsia were only
associated with ARM when additional congenital anomalies were present
(OR 3.9, 95% CI 1.3–11.6; OR 3.4, 95% CI 1.6–7.1, respectively), whereas
maternal epilepsy during pregnancy resulted in a five-fold elevated risk of
all manifestations of ARM (OR 5.1, 95% CI 1.7–15.6).
Conclusions This large European study identified maternal epilepsy,
fertility treatment, multiple pregnancy, primiparity, pre-eclampsia, and
maternal fever during pregnancy as potential risk factors primarily for
complex manifestations of ARM with additional congenital anomalies
and VACTERL.
Keywords Anal atresia, birth defects, aetiology, maternal,
pregnancy, VACTERL.
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Introduction
Congenital anorectal malformations (ARMs) are the most
frequently occurring birth defects of the digestive system,
affecting between two and six births per 10 000 births
worldwide.1 ARM is characterised by a narrowing of the
anorectal canal or anal atresia with or without fistula to
neighbouring organs. Surgical procedures are often
required at a very early age, but may not restore function-
ality completely, accounting for substantial physical and
social morbidity among patients and their families. ARM
can occur in isolation, but additional anomalies are present
in approximately 50% of cases, especially components of
the VACTERL (vertebral, anal, cardiac, tracheo-esophageal,
renal, and limb) association.2,3
Although the diversity in phenotypes and the presence
of associated malformations indicate causal heterogeneity,
most aetiological studies analyse all ARM types collec-
tively. These studies have shown contradictory results for
associations between ARM and parental lifestyle factors,
such as alcohol intake and smoking.4–7 Several studies have
been undertaken to investigate other aetiological parame-
ters for ARM, and suggesting such risk factors as maternal
pre-pregnancy overweight or obesity,6,8,9 pre-existing and/
or gestational diabetes,10,11 prolonged time to pregnancy,6
and use of assisted reproductive techniques.12–14 In addi-
tion, indications exist for a role of maternal fever during
pregnancy,6,15 maternal drug use (anti-asthmatic drugs,16
thyroid medication,17 and the benzodiazepine loraze-
pam18), folic acid supplementation,19 and parental occupa-
tional hazards.6,20 The scientific evidence for the
aforementioned potential risk factors for ARM is still
growing, but most studies lack power to perform subanaly-
ses on different manifestations of ARM. For these analyses,
large population-based case–control studies are most
appropriate.
The European Surveillance of Congenital Anomalies
(EUROCAT) is a network of population-based congenital
anomaly registries in Europe covering more than 1.7 mil-
lion births per year, collecting data on congenital anomalies
for public health, preventive, and epidemiological pur-
poses.21 The EUROCAT database enabled us to conduct a
case–control study for ARM in a large study sample, using
information from multiple sources from 17 EUROCAT
registries to study potential pregnancy-related risk factors
for ARM, and especially for subgroups with different mani-
festations of ARM.
Methods
EUROCAT
The EUROCAT database contains standardised data on
congenital anomalies recorded by each registry using
uniform definitions and coding, which are described else-
where.22–24 The data used in this study were routinely col-
lected between 1980 and 2008 by 17 EUROCAT registries
in 13 countries (Figure 1), including live births, stillbirths
from 20 weeks of gestation onwards, and terminations of
pregnancy for fetal anomaly following prenatal diagnosis.
Major malformations, syndromes, and chromosomal
abnormalities were coded according to the International
Classification of Diseases (ICD), ninth or tenth revision,
whereas specified minor anomalies were excluded according
to the EUROCAT classification.23
Case and control definitions
The study population consisted of 21 606 foetuses or
infants with ARM, syndromes, and/or chromosomal abnor-
malities. Cases were defined as live births, stillbirths, and
prenatally diagnosed foetuses with subsequent terminations
of pregnancy with all phenotypes of ARM. Foetuses or
infants with ARM being part of a recognised syndrome, or
the result of a chromosomal abnormality, as well as with
exstrophy of the cloaca or bladder, were excluded
(n = 268). The syndromes or chromosomal abnormalities
excluded (n = 217; 13% of ARM cases) mainly comprised
trisomy 21 (26%), sirenomelia (11%), and trisomy 18
(8%), as well as many others. We divided the case group
into three different manifestations of ARM: isolated ARM
(if ARM was the only malformation); ARM and one or
more other major congenital anomalies; and ARM cases
with the VACTERL association (ARM-VACTERL). Associ-
ated anomalies in the latter two manifestations of ARM
are shown in Table 1. The VACTERL association includes
vertebral defects (only thoracic and lumbar defects), ano-
rectal malformations, cardiac defects (mainly atrial septal
defect, ventricular septal defect, and tetralogy of Fallot),
tracheo-oesophageal atresia, renal malformations, and
radial limb defects. ARM-VACTERL was defined as ARM
and at least two of the additional congenital anomalies
included in the VACTERL association, which corresponds
with the VACTERL definition of the presence of at least
three of the associated malformations.25 Diagnoses of
ARM-VACTERL were assigned by the first author (C.W.)
based on this definition, and then confirmed by a clinical
geneticist (C.M.). Because no healthy controls are included
in the EUROCAT registries, by convention the control
group included live births, stillbirths, and prenatally diag-
nosed foetuses with subsequent terminations of pregnancy
with recognised syndromes (mostly single gene disorders)
or chromosomal anomalies, excluding ARM and VACTERL
(n = 45). Frequently occurring syndromes or chromosomal
abnormalities among controls were trisomy 21 (54%), tri-
somy 18 (8%), and Turner syndrome (4%). As some
pregnancy-related factors, such as pre-eclampsia and gesta-
tional diabetes, are normally not yet diagnosed before
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termination of pregnancy, the proportion of terminated
pregnancies after prenatal diagnosis in the control group
was reduced to the proportion in the case group, for rea-
sons of comparability, by randomly excluding some of
these controls (n = 6505).
Determinant definitions
In the EUROCAT database, information was recorded after
the birth of the child using multiple sources, such as hospi-
tal records, birth and death certificates, and postmortem
examinations, using uniform definitions and coding.23 A
Figure 1. Map of 17 participating EUROCAT registries with the birth years in the registries and the total numbers of cases and controls.
Table 1. Anomalies among anorectal malformation cases with additional congenital anomalies and ARM-VACTERL cases (17 EUROCAT registries;
1980–2008)
ARM and other
defects (n = 601)
ARM-VACTERL
(n = 168)
All ARM cases*
(n = 1417)
No. % No. % No. %
Skeletal anomalies 125 20.8 87 51.8 212 15.0
Vertebral anomalies** 20 3.3 57 33.9 77 5.4
Other musculoskeletal anomalies 113 18.8 48 28.6 161 11.4
Congenital heart defects 137 22.8 98 58.3 235 16.6
Cardiac defects** 97 16.1 87 51.8 184 13.0
Other cardiovascular anomalies 53 8.8 29 17.3 82 5.8
Tracheo-oesophageal atresia** 62 10.3 80 47.6 142 10.0
Urological anomalies 236 39.3 122 72.6 358 25.3
Renal anomalies** 126 21.0 107 63.7 233 16.4
Urinary tract anomalies 136 22.6 36 21.4 172 12.1
Limb defects 121 20.1 68 40.5 189 13.3
Radial limb defects** 33 5.5 50 29.8 83 5.9
Other limb defects 101 16.8 28 16.7 129 9.1
Central nervous system anomalies 89 14.8 13 7.7 102 7.2
Respiratory anomalies 50 8.3 15 8.9 65 4.6
Orofacial clefts 35 5.8 4 2.4 39 2.8
Other facial anomalies 66 11.0 20 11.9 86 6.1
Gastrointestinal anomalies 60 10.0 21 12.5 81 5.7
Abdominal wall defects 32 5.3 0 0.0 32 2.3
Genital anomalies 148 24.6 34 20.2 182 12.8
*Including isolated ARM cases, ARM cases with additional congenital anomalies, and ARM-VACTERL cases.
**Only including defects belonging to the VACTERL association.
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few registries also incorporated maternal interviews after
birth. Several foetus/infant characteristics, including gender,
survival (beyond 1 week of age), gestational age (in com-
pleted weeks) and birthweight (in grams) were recorded in
the database. In addition, information was available on
maternal age at delivery, fertility treatment (including hor-
monal treatment, artificial insemination, in vitro fertilisa-
tion [IVF], intracytoplasmic sperm injection [ICSI], and
gamete intrafallopian transfer [GIFT]), multiple pregnancy
(twins or triplets), parity (no versus one or more previous
pregnancies), maternal chronic illnesses, maternal illnesses
during first 4 months of pregnancy, and pregnancy compli-
cations. The latter three were coded according to ICD9 or
ICD10, and we included pre-existing and gestational diabe-
tes mellitus, chronic obstructive lower pulmonary diseases
(e.g. asthma and bronchitis), epilepsy, mental disorders
(e.g. depressive and anxiety disorders), fever (>38°C) dur-
ing the first 4 months of pregnancy, and pre-eclampsia,
also including eclampsia, as a proxy for placental dysfunc-
tion in this study.
Statistical analyses
Statistical analyses were performed using the statistical pack-
age SPSS 18.0 for WINDOWS (SPSS Inc., Chicago, IL, USA). We
calculated crude odds ratios (ORs) with 95% confidence
intervals (95% CIs) for potential risk factors for ARM,
namely fertility treatment, multiple pregnancy, primiparity,
and the aforementioned maternal illnesses and pregnancy
complications. Multiple logistic regression analyses were
used to calculate adjusted ORs when at least three cases were
exposed. We defined confounding factors as factors that were
either causally or accidentally associated with both ARM and
the determinant. The reporting registry was selected as an
a priori confounding factor, and was included in every
model. In addition, maternal age at delivery (divided into
 35 versus >35 years), year of birth, fertility treatment,
multiple pregnancy, primiparity, pre-eclampsia, and mater-
nal epilepsy were considered as potential confounding factors
when they were not the primary factor of interest. All factors
that changed the ORs in bivariable models were included in
the full models, from which they were excluded if the OR did
not change more than 10% upon removal. None of the
potential confounded factors proved to be true confounding
factors, except for maternal age at delivery, primiparity, and
year of birth on only a few occasions. Subanalyses were per-
formed for the different manifestations of ARM. Registries
were excluded from specific analyses when data on certain
determinants were not collected.
Results
A total of 1417 cases and 13 371 controls were eligible for
this case–control study. Of the cases, 648 had isolated ARM
(46%), 601 had ARM with one or more major congenital
anomalies (42%), and 168 were ARM-VACTERL cases
(12%). Most ARM cases with associated anomalies had uro-
logical (25%), cardiac (17%), skeletal (15%), limb (13%),
or genital (13%) anomalies (Table 1). Cases were more
often boys than girls, whereas the proportions of control
boys and girls were almost equal (Table 2). Approximately
87% of the cases were live-born, 3% were stillborn, and
10% of the pregnancies were terminated after prenatal diag-
nosis. Survival after 1 week of age was 90% among all live-
born ARM cases, 99% among live-born isolated ARM cases,
84% among live-born ARM cases with other anomalies, and
73% among live-born ARM-VACTERL cases. The propor-
tions of mothers whose children were delivered preterm
and/or had low birthweights were almost the same for live-
born cases and controls. Case mothers were slightly younger
than control mothers (28.9 and 32.2 years, respectively), of
which a larger proportion were over 35 years of age because
of the selection of controls, which included many infants or
foetuses with trisomy 21.
Tables 3 and 4 show the associations between ARM and
fertility treatment, multiple pregnancy, primiparity, and
maternal chronic illnesses, maternal illnesses during the
first 4 months of pregnancy, and pregnancy complications.
ARM seemed to be weakly associated with fertility treat-
Table 2. Characteristics of anorectal malformation cases and
controls, and their mothers (17 EUROCAT registries; 1980–2008)
ARM cases
(n = 1417)
Controls
(n = 13 371)
No.* (%) No.* (%)
Gender
Male 894 (63.5) 6748 (50.8)
Female 490 (34.8) 6487 (48.9)
Indeterminate 24 (1.7) 37 (0.3)
Birth type
Live birth 1228 (86.7) 11 210 (84.0)
Stillbirth 45 (3.2) 793 (5.9)
Termination of
pregnancy
143 (10.1) 1349 (10.1)**
Survival
(>1 week of age)***
827 (90.3) 8551 (92.4)
Preterm delivery
(<37 weeks of gestation)***
242 (21.3) 2125 (20.3)
Low birthweight
(<2500 g)***
294 (24.9) 2915 (26.9)
Maternal age at delivery
(>35 years)
180 (13.7) 4264 (33.2)
*Numbers do not add up to the total number because of missing
values.
**Artificially reduced to the same percentage as the cases.
***Only calculated for live births.
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ment (OR 1.3, 95% CI 0.9–1.8). No association was found
between isolated ARM and fertility treatment (OR 0.8,
95% CI 0.4–1.5), but an increased risk was observed for
ARM and other congenital anomalies (OR 1.6, 95% CI
1.0–2.4), and possibly for ARM-VACTERL (OR 1.6,
95% CI 0.8–3.3). Comparable odds ratios were found when
multiple pregnancies were excluded from the analyses.
Among the parents who received fertility treatment,
118 mothers were given hormonal treatment only (21 case
and 97 control mothers), 87 mothers were artificially
inseminated (ten case and 77 control mothers), 109 parents
underwent IVF (seven case and 102 control parents), 14
parents conceived through ICSI (zero case and 14 control
parents), 16 pregnancies resulted from GIFT (three cases
and 13 controls), and other unspecified techniques were
used 38 times. In fact, the only effect observed was for hor-
monal treatment (OR 2.1, 95% CI 1.3–3.4), whereas no
association was seen between ARM and IVF, ICSI, and
GIFT taken together (OR 0.8, 95% CI 0.4–1.5). In total,
398 multiple pregnancies occurred, of which 388 were twin
pregnancies and ten were triplet pregnancies. Cases were
more likely to be one of twins or triplets than controls
(OR 1.6, 95% CI 1.2–2.1), but this was only seen among
ARM cases with other congenital anomalies and ARM-
VACTERL cases (OR 1.8, 95% CI 1.2–2.8; OR 2.5, 95% CI
1.3–4.7, respectively). We found comparable results when
the analyses were restricted to infants whose parents did
not receive fertility treatment, but the association between
ARM-VACTERL and multiple pregnancy disappeared
(OR 0.5, 95% CI 0.1–3.6). Primiparity was associated with
an approximately 1.5–fold elevated risk of all manifesta-
tions of ARM. We found pre-eclampsia to be associated
with ARM (OR 2.2, 95% CI 1.2–4.0), but only among
ARM cases with other congenital anomalies (OR 3.4,
95% CI 1.6–7.1). Similar risk estimates were seen for ARM
patients whose mothers had a fever during the first
4 months of pregnancy (OR 2.2, 95% CI 0.8–5.7; OR 3.9,
95% CI 1.3–11.6, respectively). The risks of all manifesta-
tions of ARM were approximately five times increased
when the mother suffered from epilepsy during pregnancy.
In total, 14 mothers had epilepsy during pregnancy (five
cases and nine controls), of whom at least ten mothers
reported anti-epileptic drug use during the first 4 months
of pregnancy (five case and five control mothers). We did
not have information on type and dose of the anti-epileptic
drugs. Finally, pre-existing and gestational diabetes, mater-
nal chronic obstructive lower pulmonary diseases (e.g.
asthma and bronchitis), and mental disorders (e.g. depres-
sive and anxiety disorders) during the first 4 months of
pregnancy were not associated with ARM. Subanalyses
including only live births resulted in ORs that were very
similar to those in Tables 3 and 4 for all pregnancy-related
disorders (data not shown).
Discussion
In this large European registry-based case–control study,
the risk of ARM appeared to be associated with fertility
Table 3. Associations between anorectal malformations and pregnancy-related disorders (17 EUROCAT registries; 1980–2008)
Cases (n = 1417) Controls (n = 13 371) Crude OR Adjusted OR
No. (%) No. (%) (95% CI) (95% CI)
Fertility treatment* 45 (6.0) 337 (4.8) 1.3 (0.9–1.8) 1.3 (0.9–1.8)
Multiple pregnancy (twins or triplets) 56 (4.0) 342 (2.6) 1.6 (1.2–2.1) 1.6 (1.2–2.1)
Primiparity** 472 (43.2) 3472 (32.5) 1.6 (1.4–1.8) 1.6 (1.4–1.8)
Pre-eclampsia*** 14 (2.2) 71 (1.3) 1.7 (1.0–3.1) 2.2 (1.2–4.0)
Fever during the first 4 months of pregnancy*** 5 (0.8) 30 (0.5) 1.5 (0.6–3.8) 2.2 (0.8–5.7)****
Diabetes mellitus***
Pre-existing 8 (1.1) 85 (1.4) 0.8 (0.4–1.7) 0.8 (0.4–1.7)
Gestational 1 (0.1) 37 (0.6) 0.2 (0.0–1.7) –
Chronic lower obstructive pulmonary disease*** 17 (2.4) 128 (2.1) 1.2 (0.7–1.9) 1.4 (0.8–2.3)
Epilepsy during pregnancy*** 5 (0.8) 9 (0.2) 4.9 (1.6–14.6) 5.1 (1.7–15.6)
Mental disorder during the first 4 months
of pregnancy***
3 (0.5) 28 (0.5) 0.9 (0.3–3.1) 1.3 (0.4–4.3)
Maternal age at delivery, year of birth, fertility treatment, multiple pregnancy, primiparity, pre-eclampsia, and maternal epilepsy were included as
potential confounding factors, but they were excluded from the models if their removal did not change the OR by more than 10%. All factors
were adjusted for registry. An adjusted OR was calculated if more than two cases were exposed.
*Five registries were excluded as data were not available, leaving 1071 cases and 10 518 controls.
**One registry was excluded as data were not available, leaving 1325 cases and 12 774 controls.
***Six registries were excluded as data were not available, leaving 918 cases and 8347 controls.
****Adjusted for registry and year of birth.
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treatment, multiple pregnancy, primiparity, pre-eclampsia,
maternal fever during the first 4 months of pregnancy, and
epilepsy during pregnancy. These pregnancy-related disor-
ders were mainly found to increase the risk of ARM when
ARM occurred in combination with other anomalies,
whether or not belonging to the VACTERL association.
The EUROCAT network provides many possibilities for
large-scale epidemiological studies on congenital anomalies.
The study sample of 1417 ARM cases was the largest sam-
ple ever studied, which made it possible to investigate dif-
ferent manifestations of ARM. The importance of
performing these subanalyses was emphasised by risk esti-
mates that varied between different manifestations of ARM.
Causal heterogeneity may exist because of differences in the
time windows of exposure or the underlying biological
mechanisms. Despite the large study sample, the power
may have been insufficient to detect moderate effects of
specific risk factors for ARM, especially in ARM-VACTERL
cases. As EUROCAT only collects data on the pregnancies
of the infants/foetuses affected, we used controls that had
malformations instead of controls with no malformations.
Teratogenicity non-specificity bias may occur when a cer-
tain exposure leads to malformations in both cases and
controls. To reduce this type of bias, only controls with
recognised syndromes or chromosomal abnormalities were
included, under the assumption that these abnormalities
originated becasue of genetic defects only. Because these
syndromes and chromosomal abnormalities arise before or
during conception, it is not likely that pregnancy-related
factors influenced their occurrence. Furthermore, previous
studies argued that these types of congenital anomalies are
suitable and representative sources of controls.26,27 A few
potential risk factors, including gestational diabetes mell-
itus, chronic lower obstructive pulmonary disease and
mental disorders, seemed to be under-reported in mothers
of both cases and controls, but the figures for most
determinants in controls were similar to those found in the
general pregnant population.28,29 As a postmortem exami-
nation after a stillbirth or for prenatally diagnosed foetuses
with subsequent termination of pregnancy was not always
performed, some controls may have had ARM. This could
have resulted in a dilution of the effects that were found.
Table 4. Adjusted associations between different manifestations of anorectal malformations and pregnancy-related disorders (17 EUROCAT
registries; 1980–2008)
Isolated ARM cases
(n = 648)
ARM and other defects
(n = 601)
ARM-VACTERL
(n = 168)
No. Adjusted OR
(95% CI)
No. Adjusted OR
(95% CI)
No. Adjusted OR
(95% CI)
Fertility treatment* 13 0.8 (0.4–1.5)** 23 1.6 (1.0–2.4) 9 1.6 (0.8–3.3)
Multiple pregnancy (twins or triplets) 18 1.1 (0.7–1.8) 27 1.8 (1.2–2.8) 11 2.5 (1.3–4.7)
Primiparity*** 213 1.5 (1.3–1.8) 201 1.5 (1.3–1.9) 58 1.8 (1.3–2.6)
Pre-eclampsia**** 3 1.3 (0.4–4.1) 9 3.4 (1.6–7.1) 2 1.8 (0.4–7.4)
Fever during the first 4 months of pregnancy**** 0 – 4 3.9 (1.3–11.6) 1 2.1 (0.3–15.8)
Diabetes mellitus****
Pre-existing 3 0.8 (0.3–2.5) 4 1.2 (0.4–3.2)***** 1 0.8 (0.1–5.9)
Gestational 1 0.5 (0.1–3.9) 0 – 0 –
Chronic obstructive lower pulmonary disease**** 7 1.4 (0.6–3.0) 7 1.3 (0.6–2.9) 3 1.4 (0.4–4.7)******
Epilepsy during pregnancy**** 2 4.5 (1.0–20.8) 2 4.6 (1.0–21.2) 1 7.1 (0.9–56.5)
Mental disorder during the first 4 months
of pregnancy****
2 1.4 (0.3–6.1) 1 0.7 (0.1–5.4) 0 –
The same controls were used as in Table 3.
Maternal age at delivery, year of birth, fertility treatment, multiple pregnancy, primiparity, pre-eclampsia, and maternal epilepsy were included as
potential confounding factors, but they were excluded from the models if their removal did not change the OR by more than 10%. All factors
were adjusted for registry. Crude ORs were presented if less than three cases were exposed.
*Five registries were excluded as data were not available, leaving 460 isolated ARM cases, 470 ARM cases with other defects, 141 ARM-VACTERL
cases, and 10 518 controls.
**Adjusted for registry and primiparity.
***One registry was excluded as data were not available, leaving 595 isolated ARM cases, 569 ARM cases with other defects, 161 ARM-
VACTERL cases, and 12 774 controls.
****Six registries were excluded as data were not available, leaving 390 isolated ARM cases, 406 ARM cases with other defects, 122 ARM-
VACTERL cases, and 8347 controls.
*****Adjusted for registry and maternal age.
******Adjusted for registry and year of birth.
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Differential misclassification of exposure status because of
poorer recording of exposures for controls compared with
cases is unlikely, as information on pregnancy-related fac-
tors was obtained from hospital records by the EUROCAT
registry, with already-existing data gathered prospectively
during pregnancy for most infants in our study, regardless
of the type of malformation. Only a few registries used
maternal interviews after birth, but pregnancy-related fac-
tors, such as fertility treatment, multiple pregnancy, primi-
parity, pre-eclampsia, and other maternal disorders, are not
expected to be prone to recall bias. A limitation of this reg-
istry-based study was the lack of information on parental
lifestyle factors and of detailed information on certain
potential risk factors, such as zygosity in multiple pregnan-
cies, the type of fertility problems of the parents, and spe-
cific information on illnesses and drug use. Therefore,
residual confounding cannot be excluded. All associations
were adjusted for the registry, which is appropriate as small
differences are existent between the EUROCAT registries.
Although we described some potential biases that are usu-
ally associated with observational studies, we expect that
these biases only influenced our findings to a minimal
extent.
Approximately 54% of the ARM cases without syn-
dromes, chromosomal abnormalities, or cloacal or bladder
exstrophy had one or more additional congenital anoma-
lies. Among all ARM cases up to 62% had additional con-
genital anomalies. This is in line with previous studies that
reported percentages of between 40 and 70%, usually
including syndromes and chromosomal abnormalities.2,30
Urological (25%) and cardiac (17%) malformations
appeared to be the most prevalent additional malforma-
tions, which also confirms other studies.2,30 The male/
female ratio of 1.8 among ARM cases was higher than pre-
viously described ratios of 1.2–1.4.6,30 Females more often
suffer from mild and unrecognised phenotypes of ARM
without clinical symptoms than males. In this
registry-based study, the diagnoses of these mild pheno-
types of ARM may have been missed or delayed, which
could have led to a relatively high male/female ratio.
To our knowledge, this is the first study to perform
subanalyses on associations between fertility treatment and
different manifestations of ARM. Even after adjustment for
multiple pregnancy, we found fertility treatment to be asso-
ciated with ARM in combination with other defects only,
and we found an effect for hormonal treatment without
IVF or ICSI in general. In contrast, clomiphene citrate, a
hormonal drug for subfertility treatment, was not found to
be associated with ARM in a study on the effect of this
drug on major birth defects.31 Other studies showed that
assisted reproductive techniques, including IVF and ICSI,
increased the risk of several major birth defects, including
ARM.12–14 However, these studies did not perform subanal-
yses for different manifestations of ARM. Although con-
trasting, all of these findings seem to point towards an
association between ARM and fertility treatment. This may
be caused by epigenetic mechanisms, which were also
described for associations between fertility treatment and
certain syndromes (e.g. Beckwith–Wiedemann syn-
drome);32,33 however, it may also indicate that the underly-
ing subfertility of the parents is the main risk factor in the
aetiology of ARM.
We found an over-representation of ARM with additional
congenital anomalies and ARM-VACTERL among multiple
pregnancies, whereas few other researchers found increased
numbers of heterogeneous groups of gastrointestinal atre-
sias, including ARM, in multiple pregnancies.34,35 Doyle
et al.34 showed the proportion of chromosomal abnormali-
ties to be lower in multiple pregnancies, which could corre-
spond with a decreased number of multiple pregnancies
among our controls. As more recent studies did not confirm
this result, it is debatable whether our ORs for multiple
pregnancies were overestimated.35,36 Primiparity was associ-
ated with all manifestations of ARM, and pre-eclampsia was
associated with ARM and additional congenital anomalies
only, although the risk estimates for primiparity may be
slightly inflated as firstborns are relatively uncommon
among controls with trisomy 21.37 Interestingly, multiple
pregnancy, primiparity, and pre-eclampsia are all factors
that may reflect situations in which the placenta insuffi-
ciently supplies the foetus with nutrients and hormones.
Therefore, we hypothesise that placental insufficiency in
early pregnancy partly explains the associations found, espe-
cially those for ARM occurring in combination with other
congenital anomalies. Similar results have been found for
hypospadias, a frequently occurring congenital malforma-
tion among boys.38 Although the rates of low birthweight
among cases and controls were almost equal, these were
high compared with controls without malformations.28 Low
birthweight may also be a consequence of placental insuffi-
ciency, which strengthens our placental insufficiency
hypothesis. Another biological mechanism underlying the
associations between ARM and multiple pregnancy and
primiparity may be a disturbed androgen–estrogen balance,
as endogenous levels of free oestradiol are increased in first
and multiple pregnancies.39 Free oestradiol levels also
increase with an increasing body mass index of the
mother,40 and maternal overweight and obesity have consis-
tently been identified as risk factors for ARM.41
Although adverse effects of maternal epilepsy and/or anti-
epileptic drug use on birth defects have already been
shown,42 we found a five times increased risk of ARM in
infants/foetuses of mothers with epilepsy during pregnancy.
Unfortunately, we were not able to study associations
between ARM and the different types and doses of anti-
epileptic drugs, as no information on these was available. It
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is unclear whether congenital anomalies result from the tera-
togenic effects of anti-epileptic drugs alone, or are partly the
result of the underlying epilepsy itself. Previously, a reduced
risk of ARM was shown after periconceptional folic acid sup-
plementation.19 This may explain the association between
ARM and maternal epilepsy during pregnancy, as treatment
with most anti-epileptic drugs was associated with reduced
folate serum levels.43 In agreement with our previous studies
on parental risk factors for ARM,6,15 maternal fever during
the first 4 months of pregnancy was found to be associated
with ARM, mainly in infants/foetuses with additional con-
genital anomalies. A recent meta-analysis reported an
increased risk of ARM for maternal pre-existing or gesta-
tional diabetes mellitus,41 but we could not confirm these
findings, possibly because of the underreporting of pre-
existing or gestational diabetes among cases and controls,
and because of the small numbers in the case groups.
Conclusion
This is the first study emphasising the importance of per-
forming subanalyses on different manifestations of ARM.
Our findings suggest the involvement of multiple preg-
nancy, primiparity, and pre-eclampsia, factors that are pos-
sibly related to placental insufficiency or a disturbed
androgen–estrogen balance, as well as fertility treatment,
maternal epilepsy, and fever during the first 4 months of
pregnancy in the aetiology of ARM. These pregnancy-
related disorders mainly seem to play a role in complex
phenotypes of ARM, in which additional congenital anom-
alies are present. Only maternal epilepsy and primiparity
were found to be involved in the occurrence of isolated
ARM. Although these factors increased the risk of ARM
1.5–5.0 times, the absolute risks of having a child with
ARM were relatively low, ranging between 0.05 and 0.26%
for each potential risk factor. In addition to relative and
absolute risks, however, these findings also provide clues
about the pathophysiological mechanisms involved in the
aetiology of ARM, which may in turn guide further
research, preventive strategies, and health care for ARM
patients in the future.
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